RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases (Q44204260)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 November 2002
edit
Language Label Description Also known as
English
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
scientific article published on 4 November 2002

    Statements

    RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. (English)
    Graham Casey
    Phillippa J Neville
    Sarah J Plummer
    Ying Xiang
    Lisa M Krumroy
    Eric A Klein
    William J Catalona
    Nina Nupponen
    John D Carpten
    John S Witte
    4 November 2002
    581-583

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit